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Glossary 
 
bp  basepair 
cp  copy 
Cq  quantification cycle 
CRM  certified reference material 
CTAB  Cetyl trimethyl ammonium bromide 
EA  European co-operation for Accreditation 
EC  European Commission 
ENGL  European Network of GMO Laboratories 
EU European Union 
EURL-GMFF European Union Reference Laboratory for Genetically Modified Food and 
Feed 
GM(O) genetically modified (organism) 
GUM  Guide to the Expression of Uncertainty in Measurements 
IEC  International Electrotechnical Commission 
IHCP  Institute for Health and Consumer Protection 
ILC  interlaboratory comparison (also referred to as interlaboratory study) 
IUPAC International Union of Pure and Applied Chemistry 
IRMM  Institute for Reference Materials and Measurements 
ISO  International Organization for Standardization 
JRC  Joint Research Centre 
LOD  limit of detection 
LOQ  limit of quantification 
LLP  low level presence 
MP  microlitre pipette 
MPR  minimum performance requirements 
MU  measurement uncertainty 
N  number of samples 
n  number of measurement replications on the same sample 
PCR  polymerase chain reaction 
qPCR  quantitative (real-time) PCR 
PT  proficiency testing 
R2  coefficient of determination 
RSD   relative standard deviation 
SI  International System of Units 
TF  Task force 
Taq   Thermus aquaticus (polymerase)  
WG  working group 
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Abstract 
 
The aim of this guidance document is to facilitate harmonised flexible scope accreditation 
within Europe, according to ISO/IEC 17025:2005 related to quantitative testing of genetically 
modified organisms (GMOs) by quantitative real-time polymerase chain reaction (qPCR) for 
GM events authorised in the EU or which are in the authorisation process. 
 
This document gives guidance to and is intended for laboratories that are considering to 
acquire a flexible scope of accreditation according to ISO/IEC 17025. At the same time it 
aims to provide information for assessors involved in the accreditation process of these 
laboratories.  
 
This guidance document has been written by members of the Task Force (TF) Flexible scope 
accreditation, which has been initiated by European Commission, Joint Research Centre, 
Institute for Reference Materials and Measurements (EC JRC-IRMM, Geel, BE). After an 
extensive commenting phase it has been submitted to the European co-operation for 
Accreditation (EA) in February 2013 for consideration as an EA guidance document.  
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1 Scope of the guidance document 
 
The aim of this guidance document is to ensure harmonised flexible scope accreditation 
within Europe, according to ISO/IEC 17025:2005 [1 ] related to quantitative testing of 
genetically modified organisms (GMOs). Considering that polymerase chain reaction (PCR) 
is the method of choice in the European Union (EU) for the identification and quantification 
of GMOs, this document refers exclusively to quantitative real-time PCR (qPCR) and GM 
events authorised in the EU. A validated quantification method is published by the European 
Union Reference Laboratory for Genetically Modified Food and Feed (EURL-GMFF) for 
each of the authorised events as laid down in Regulation (EC) No 1829/2003 [2]. This 
document is applicable to methods for GM events which were previously authorised in the 
EU or which are in the authorisation process, provided that the method validation has been 
completed and that a certified reference material (CRM) is available as requested in the low 
level presence (LLP) regulation for feed [ 3 ]. This guidance document does not cover 
screening methods, qualitative PCR methods or methods to quantify GM events not 
authorised in the EU. 
In the future, an extension to this document might be considered dealing with those specific 
cases. However, some general principles illustrated might also be applicable for the methods 
currently not covered. 
 
This guidance document is intended for laboratories that are considering acquiring a flexible 
scope of accreditation according to ISO/IEC 17025, and aims to provide information for 
assessors involved in the accreditation process of these laboratories. Therefore, it therefore 
addresses primarily laboratory managers and assessors for ISO/IEC 17025. 
This document refers to other documents, which may be reviewed and updated. As a 
consequence this guidance document will be updated when needed. ISO/IEC 17025 remains 
the authoritative document and, in case of dispute, the individual accreditation bodies will 
adjudicate on unresolved matters. 
 
This guidance document has been written by members of the Task Force (TF) Flexible scope 
accreditation, which has been initiated by European Commission, Joint Research Centre, 
Institute for Reference Materials and Measurements (EC JRC-IRMM, Geel, BE) and which 
reported to the European Network of GMO Laboratories (ENGL). It passed an extensive 
commenting phase involving the ENGL and has been submitted to the European co-operation 
for Accreditation (EA) in February 2013 for consideration as an EA guidance document.  
We welcome further constructive feedback on this European technical guidance document 
for the flexible scope accreditation of laboratories quantifying GMOs. All correspondence 
should be sent by email to JRC-IRMM-GMO@ec.europa.eu with the subject heading 
'flexible scope document'. 
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2 Introduction 
 
Legislation in the EU regulates the placing on the market of food and feed consisting of, 
containing or produced from GMOs. They are referred to as 'GM food and feed' and require 
authorisation before being placed on the market in the EU. Food and feed products which 
contain, consist of or are produced from GMOs in a proportion higher than 0.9 per cent of the 
food and feed ingredient considered individually or food or feed consisting of a single 
ingredient, need to be labelled [2]. In this context, it needs to be noted that the labelling 
threshold is applicable for adventitious presence of GMOs, while GMOs added on purpose 
need to be labelled independent from a threshold. 
Additionally feed may contain 0.1 mass per cent of a GM event which was previously 
authorised in the EU or for which an authorisation process is pending [3]. 
 
During the EU authorisation process, the applicant seeking authorisation for a GM event 
needs to ensure that a reference material for the GM event is available and that an event-
specific quantification method has been successfully validated and is published by the 
EURL-GMFF. Successfully validated methods fulfil the minimum performance criteria laid 
down by the EURL-GMFF in [4]. As a consequence, reference materials and validated 
methods are publically available to GMO testing laboratories for the GM events covered by 
this guidance document. 
 
As the number of new GM events for which authorisation is granted, is increasing rapidly 
every year and as GMO testing laboratories are obliged to operate under ISO/IEC 17025 
accreditation [5], the testing laboratories need to take up new GM events within their scope 
of accreditation in a timely manner. As a consequence, a flexible scope accreditation is 
requested by more and more GMO testing laboratories. The number of matrices on which the 
quantification method needs to be applied is also increasing. 
 
3 Flexible scope — ISO/IEC 17025, Section 1.2 
 
The accreditation of laboratories is based on a defined scope of accreditation which is clear 
and unambiguous, and provides the laboratory and other interested parties with a detailed list 
of the tests for which the laboratory is accredited. A precise description of the specific tests 
for which the laboratory is deemed competent is needed for a fixed as well as flexible scope.  
A fixed scope of accreditation requires an evaluation of the laboratory’s competence by the 
accreditation body for each new test that is added to the scope. A flexible scope allows 
adding a new test based on a competence evaluation carried out by the laboratory. This 
inclusion of a new test to the flexible scope is verified by the accreditation body a posteriori. 
 
It has become desirable to establish mechanisms which permit more laboratories to extend 
the range of their scope on the basis that their competence related to GMO quantification by 
qPCR has already been evaluated. 
 
A flexible scope for the measurement of the GM content is needed by the laboratories, 
allowing the quantification of GM events newly authorised in Europe without prior approval 
by the accreditation body. As the necessity for such flexibility is clearly established, the 
additional efforts to develop, implement and maintain an extended management system that a 
flexible scope requires can be beneficial. 
 
9
 
A laboratory’s scope of accreditation is laid down in the accreditation document and refers to 
one or more of the following items. 
 
• Product 
The materials, in which the GM content is quantified, can be classified as being seed 
or food or feed, including their ground forms. Accredited laboratories are in some 
cases accredited only for one of these specific products. 
 
Note: 'Seed' has to be understood in this context as seeds suitable for agricultural 
purposes. Laboratories accredited for food or feed matrices do not test seeds but test 
food/feed products, while the food/feed can consist of grains (harvested material). 
 
Furthermore, laboratories can be explicitly accredited for GM quantification of 
vegetative parts from plants (e.g. potato tubers, plant leaves), while others are 
accredited for GM quantification in plant material in the general sense. 
 
• GM event 
GM event refers to the unique DNA recombination event that took place in one plant 
cell, which was then used to generate transgenic plants. GM event-specific methods 
are targeting the unique insertion region of the DNA construct (junction between 
transgenic and conventional DNA sequence, further referred to as the transgene-
specific DNA target).  
 
The concentration of the GM event is calculated as the ratio of two small (e.g. 60 to 
150 bp) DNA fragments present in DNA extracted from the material tested. The 
relative concentration of those two fragments amplified by qPCR is determined. One 
of the two fragments is chosen to be specific to a particular GM event whereas the 
other fragment is specific to the taxon or species (further referred to as the taxon-
specific DNA target). The qPCR measurement result is expressed as ratio of those 
two relative DNA fragment concentrations. 
 
Note: The measurement result can be expressed in GM mass fractions or in GM DNA 
copy numbers. In this context the material used for the calibration has to be taken into 
account.  
 
• Analytical procedure 
The analytical procedure applied for the quantification of GMO is composed of a 
DNA extraction method, which can be based on different principles, and a DNA 
quantification method based on the measurement principle qPCR. 
 
Note: Due to the fact that the here concerned GM events are authorised in the EU, 
European standardised methods validated by interlaboratory comparison (ILC) 
organised by the EURL-GMFF and completed with the help of the ENGL are 
available. 
 
As the methods applied for GM labelling in the EU need to be event-specific [6], all 
methods concerned here are based on qPCR.  
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• Range of measurements 
For some accredited laboratories, the scope specifies additionally the content range of 
measurement results for which the accreditation is valid. 
 
Note: Specifying a range of measurements might be meaningful when other analytical 
techniques than qPCR are concerned. 
 
3.1 Levels and degrees of flexibility 
 
The flexibility of the scope may cover three categories. For each of the below mentioned 
categories (Sections 3.1.1, 3.1.2 and 3.1.3) the level of flexibility can be adjusted and 
combined depending on the needs and degree of expertise of the accredited laboratory.  
 
Figure 1 schematically compares a fixed accreditation scope with the flexible accreditation 
scope. In general, it is reasonable to grant a flexible scope to a laboratory that has proven its 
competence for qPCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of a typical fixed scope for a defined GM event (e.g. 
MON810 and hmg) measured by a defined analytical procedure (e.g. CTAB and TaqMan 
chemistry) in a defined product (e.g. maize seeds). The possibilities for a flexible scope 
within the three categories are indicated by the arrows.  
3.1.1 Flexibility concerning the product 
 
This flexibility allows for changes in the specific products tested if this can be done using the 
same testing techniques for the test parameters for which the laboratory is already accredited. 
The level of flexibility will depend on the products included in the validation of the method. 
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A typical fixed scope could be for MON810 maize seed, a flexible scope could be on GM 
seeds (in this case not limited to GM maize but extended to any other GM species) or further 
extended to GM plant materials (in this case not limited to GM seeds but extended to other 
parts of the maize plant (e.g. leaves)). 
 
Flexibility concerning the product can be extended to products processed in different ways. 
For example, GM rice can be processed into different product types, such as rice flour, flaked 
rice grains, rice starch, roasted cereals obtained from rice or pre-cooked rice. 
3.1.2 Flexibility concerning the GM event 
 
GMO quantification by qPCR using TaqMan chemistry validated per GM event (e.g. for the 
MON810, MON863 or DAS1507 maize event) could be considered to be part of a fixed 
scope. However, a scope defined as 'quantification of GM maize' or 'quantification of GM 
species' by qPCR would provide different levels of flexibility. In both cases the same 
measurement principle will be used (qPCR). The only difference is the DNA targeted by the 
primers and probes. In the first case (quantification of GM maize) only the event-specific 
target changes, while the taxon-specific remains limited to one species (maize). For changes 
of the taxon-specific target the reader is referred to Section 3.1.3. In the second case 
(quantification of GM species) both targets change. 
3.1.3 Flexibility concerning the analytical procedure 
 
This flexibility allows for changes in the analytical procedure of a particular method for a 
specific product for which the laboratory is accredited. This can concern DNA extraction 
methods as well as DNA quantification methods by qPCR.  
 
For example, a typical fixed scope could be a DNA extraction using the CTAB method, a 
flexible scope could be a DNA extraction using other types of extraction methods. 
 
Note: Changes to improve the performance of the method in terms of higher yield of DNA or 
better PCR quality may concern the sample intake, sample preparation or clean-up procedure 
for a specific matrix. 
 
An extraction method used for another material (than the one it was verified for) may have to 
be adapted to meet the DNA quality criteria required for qPCR. 
Different extraction methods may be needed to extract DNA from processed food or feed 
containing the same species. 
 
For PCR, parameters such as PCR efficiencies and PCR linearities can be used to monitor the 
effects of small changes (e.g. changes in the PCR annealing temperatures, in the primer or 
probe concentrations, changes in the nature of the fluorescent probes and quenchers) on the 
performance of the testing method. 
 
Laboratories may also decide to replace a set of PCR primer specific to a particular taxon-
specific gene (e.g. the replacement of adh1, used as taxon-specific gene for maize with 
another taxon-specific gene such as hmg; or the replacement of a set of primers targeting 
different parts of the same genetic element). 
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In each case, the laboratory would need to demonstrate during method verification that with 
those changes, the criteria of acceptance of the validated method are still met. 
 
Methods validated by the EURL-GMFF and concerned in this document have proven during 
validation that the minimum performance requirements (MPR) for the regulatory purpose laid 
down in [4] can be fulfilled. For the implementation the performance criteria required and to 
be achieved by the GMO testing laboratory need to be clearly described in a specific 
verification plan and need to fulfil the requirements laid down in [7]. It is the obligation of 
the laboratory to demonstrate during method verification that the method is fit for purpose in 
this laboratory and can be applied under a flexible scope accreditation. 
3.2 Additional specific requirements  
 
In order to acquire a flexible scope accreditation, the laboratory holding a fixed scope 
accreditation needs to introduce a number of procedures governing the management of the 
flexible scope and ensuring the integrity of the introduction of further GMO quantification 
methods. The laboratory needs to set out clear criteria when a working instruction for a 
method is considered under the flexible scope. 
 
An explicit statement needs to be produced declaring that the method is to be included in the 
flexible scope of accreditation, showing the timing of the inclusion and the criteria on which 
this inclusion is based. The scope of accreditation needs to be updated when new methods are 
included according to the guidelines of the individual accreditation body. Additional 
requirements can be found in the document EA requirements for the accreditation of flexible 
scopes [8]. 
 
4 Laboratory sample preparation — ISO/IEC 17025, Section 5.4 
 
Some indications and general recommendations related to sample preparation are given in the 
International Standards ISO 21571:2005 [9] and ISO 24276:2006 [10]. Furthermore, the 
ENGL is working on a guideline dedicated to sample preparation. 
 
The following aspects have to be taken into account: 
• homogeneity of the laboratory sample; 
• representativeness of the analytical sample and test portion with regard to the 
laboratory sample; 
• measures to avoid cross-contamination have to be taken by the laboratory 
(ensuring premises are compliant, including dusting and  cleaning). 
 
Specific recommendations for those aspects can be found in the following documents: 
• test portion and particle size: ISO 21571:2005, Section 5.1 [9] 
• liquid samples: ISO 21571:2005, Section 5.1.2 [9] 
• pasty samples: ISO 21571:2005, Section 5.1.2 [9] 
• viscous samples: ISO 21571:2005, Section 5.1.2 [9] 
• heterogeneous sample: ISO 21571:2005, Section 5.1.2 [9] 
• premises: ISO 24276:2006, Section 5.3.2 [10] 
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5 Method verification and measurement uncertainty estimation — ISO/IEC 
17025, Sections 5.4.5 and 5.4.6 
5.1. General considerations 
 
An accredited laboratory shall have a management system in place to provide objective 
evidence that the personnel is adequately qualified and trained to perform the analysis 
(ISO/IEC 17025:2005, Section 5.2 [1]). In addition, a metrology system shall ensure that the 
equipment used is periodically calibrated (ISO/IEC 17025:2005, Section 5.5 [1]). When a 
method validated by ILC is used by an accredited laboratory, the laboratory must, prior to its 
use, ensure that the chosen method shows performance characteristics as good as or better 
than those assessed in the ILC [4]. This verification process must be documented and 
recorded in the quality system [7]. If the method performance characteristics investigated in 
the ILC cannot be met, then the method performance needs to be improved by the laboratory.  
 
The laboratory shall establish the criteria for the acceptance of the verification results. These 
criteria need to be set in such a way that successful verification confirms that the method is 
suitable for the intended purpose. The laboratory must record the procedure used, the results 
obtained and a statement on whether the method is fit for the intended purpose, e.g.: 
• design and planning of the verification 
• description of the method applied 
• acceptance criteria and performance requirements, as decided by the 
laboratory 
• test records of the verification measurements 
• documentation of the conclusion 
5.2 Method verification 
 
Method verification concerns in the given context methods that have already been validated 
by third parties. 
 
The document Definition of minimum performance requirements for analytical methods of 
GMO testing [4] used by the EURL-GMFF for the assessment of GMO detection methods 
submitted by applicants within the frame of the Regulation (EC) No 1829/2003 [2] should be 
used as a basis for assessing the performance of a method. Additionally, a working group 
(WG) of the ENGL has published guidelines for the implementation/adaptation of such 
validated methods in control laboratories of the EU. The document entitled Verification of 
analytical methods for GMO testing when implementing interlaboratory validated methods 
[7] gives guidance on how to verify that a validated method performs sufficiently for control 
purposes in a given laboratory. The guidelines are intended for laboratories accredited with a 
fixed or flexible scope under ISO/IEC 17025. In the following paragraphs, only the general 
information contained in the guidelines published by the ENGL WG is summarised. 
 
ISO/IEC 17025 accreditation states that ‘The laboratory shall confirm that it can properly 
operate standard methods before introducing the tests or calibrations’. If the standard 
method changes, the confirmation shall be repeated (ISO/IEC 17025:2005, Section 5.4.2 [1]). 
In GMO detection laboratories, the event-specific method provided during the application for 
authorisation is used for GMO quantification. This method has been validated by the EURL-
GMFF in collaboration with the ENGL and is available via the website of the EURL-GMFF 
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and the Compendium of reference methods for GMO analysis [ 11 ]. This compendium 
contains qPCR-based GMO detection methods that have been validated through ILCs 
according to ISO 5725-2:1994 [12] and/or the IUPAC protocol [13]. Before applying such a 
validated method for GMO testing, the GMO testing laboratory needs to confirm that it is 
able to properly operate the method. This confirmation is done during method verification.  
5.2.1 Parameters for method verification  
 
The following sections describe the parameters to be studied for the verification of validated 
methods for the quantification of GMOs. During the verification process, a laboratory should 
ensure compliance with the requirements described in the following documentary standards 
ISO 21569:2005 [14], ISO 21570:2005 [15], ISO 21571:2005 [9] and ISO 24276:2006 [10]. 
 
As a matter of principle, a method should be implemented as validated in the ILC, without 
introducing modifications. If single elements like for example the brand of a ready-to-use 
reaction mix or Taq polymerase, the PCR reaction volume, the primer and probe 
concentrations, and/or PCR cycling parameters are modified, it needs to be ensured that the 
MPR laid down in [4] are still fulfilled. 
 
At the time of the method verification CRMs are available to the laboratories. Therefore, the 
verification process is preferably conducted on CRMs. If no CRM is available at the proper 
concentration levels, additional steps have to be considered (Section 7). 
5.2.1.1 Sample preparation 
 
An essential step for obtaining reliable GM measurement result is the sample preparation or 
grinding of the samples to be analysed. Grinding helps to ensure the homogeneity of the 
tested batch and thus the representativeness of the test portion analysed. Moreover, it can 
facilitate the DNA extractability. 
 
In general, more DNA can be extracted per mass unit from a sample with a smaller average 
particle size. It is therefore important to determine the minimum sample size and to consider 
the maximum particle size required to reach a specific limit of detection (LOD) using a given 
sample intake. For example, seed/grain samples contaminated at the level of the LOD of the 
method should be ground and tested each independently in six test portions. If all test 
portions test positive, the grinding conditions are suitable and the test portion can be 
considered as sufficiently homogeneous. 
5.2.1.2 DNA extraction 
 
The DNA extraction method should provide DNA of suitable quality and quantity for 
subsequent analysis. DNA extraction methods present a crucial step, as the quality and 
quantity of DNA extracted can significantly affect the final result. Two cases can be 
considered depending on whether or not the applied DNA extraction method has been 
previously appropriately validated. 
 
If the DNA extraction method has been previously validated (either by the EURL-GMFF or 
another organisation) for the purpose in question (similar matrix, etc.), the laboratory has to 
check whether the method delivers DNA extracts suitable for PCR and meets the criteria set 
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out in the document Verification of analytical methods for GMO testing when implementing 
interlaboratory validated methods [7]. 
 
Procedure: DNA extraction is carried out at least twice (three times recommended) each time 
on two test portions, if possible on different days and by different operators. 
 
Acceptance criteria: The DNA extractions should meet the acceptance criteria for DNA 
concentration and quality (e.g. by checking amplification efficiency and presence of 
inhibitors by qPCR) [7]. 
 
Note: DNA extraction methods applied to one matrix may not be suitable for other matrices, 
while the intention is to apply the extraction method on different matrices. For the 
verification of a DNA extraction method the tested matrix does not necessarily have to 
contain GMOs. However, it needs to be tested on the GM event if the event modifies the 
composition of the material in a way that might have an impact on the DNA extractability 
(e.g. starch-modified potatoes). 
 
If the DNA extraction method has not been previously validated for the purpose, the 
laboratory has to check whether the method delivers DNA extracts suitable for PCR. This is 
usually done in a single laboratory validation. 
 
Procedure: The DNA extraction is carried out at least five times on the same sample, if 
possible on different days and by different operators. 
 
Acceptance criteria: The DNA extract should meet the acceptance criteria for DNA 
concentration and quality (e.g. by checking amplification efficiency and presence of 
inhibitors by qPCR) which have been reasonably set by the laboratory, e.g. by using 
acceptance criteria from other internationally validated extraction methods for the same plant 
species, or for the same type of food or feed product [7]. 
 
The laboratory needs to verify DNA extraction methods for the most relevant matrices for 
which it requests a flexible scope accreditation. For food and feed products at least three 
different product types should be tested per species (e.g. rice flour, flaked rice grains, rice 
starch). If the laboratory only deals with one specific product type, the verification can be 
based on this one product type only. 
5.2.1.3 DNA concentration 
 
Procedure: After applying the DNA extraction method on routine samples, the concentration 
of DNA in the extracts should be measured. 
 
Acceptance criterion: In the verification process, when a DNA extraction method is applied 
to the same matrix as in the validation study, the amount of DNA extracted should be at least 
equal to the results obtained in that study. The method should provide DNA in an appropriate 
amount for the intended analysis, at least enough to meet the desired LOD and LOQ and the 
required representativeness.  
Note: The DNA yield of an extraction method depends strongly on the material used. Even 
the same type of matrix can lead to differences (e.g. fresh maize grains versus old grains). If a 
DNA extraction method does not give an appropriate yield for the intended analysis on a 
particular matrix, the LOD will be affected [7] and the impact needs to be evaluated. 
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For the impact of the particle size check Section 5.2.1.1. 
5.2.1.4 Absence of inhibitors 
 
Inhibition of a PCR reaction may depend on the sample from which the DNA is extracted and 
on the DNA extraction method applied. Therefore an inhibition check needs to be carried out 
unless it can be proven that a certain sample/method combination does not lead to inhibition. 
 
Procedure: Each DNA extraction replicate obtained from the sample is diluted as done during 
routine analysis (further referred to as working dilution). From this working dilution, a 
dilution series of, for example, four concentrations is analysed by qPCR (at least two PCR 
replicates per dilution). The measurement results are used to obtain a calibration curve. 
 
The preferred PCR assay for the inhibition test is targeting the taxon-specific DNA. The total 
DNA amount in the working dilution should be at least the same as the total DNA amount 
intended to be used in the verification process and in the later routine analysis (e.g. the DNA 
amount indicated in the PCR protocol for the taxon-specific measurement). 
 
Acceptance criterion: From a four-fold calibration curve the average difference (ΔCq) 
between the measured Cq value of the dilution and the calculated Cq value of the further 
dilution (calculated from extrapolation of the Cq values of the following dilutions) should be 
< 0.5 [measured Cq – extrapolated Cq < 0.5] and the slope of the calibration curve should lie 
between –3.1 and –3.6 [7]. 
 
If the extracted DNA solution contains inhibitors, the DNA has to be further purified or 
diluted to the level where no inhibition of the PCR reaction is observed before it is used for 
qPCR. 
5.2.1.5 Specificity 
 
Specificity has already been investigated in the context of method validation; the specificity 
does therefore not need to be experimentally investigated during verification. In case of doubt 
the specificity of the method can be verified experimentally using e.g. CRMs. Additionally it 
can be helpful to investigate the absence of high sequence similarity in silico between the 
amplicons and a database using dedicated algorithms for comparing primary DNA sequence 
information (e.g. Basic Local Alignment Search Tool). However, it has to be born in mind 
that the transgenic sequence cannot be covered by the latter approach. 
5.2.1.6 Linear range, R2 coefficient, and amplification efficiency 
 
Procedure: Linear range, coefficient of determination (R2), and amplification efficiency are 
verified simultaneously from calibration curves when testing other parameters, such as 
trueness and precision. The mean values of at least two calibration curves should be taken. 
 
Acceptance criterion for linear range: The linear range must cover the values corresponding 
to the expected use which is typically the legal labelling threshold of 0.9 % for authorised 
events [2] or 0.1 (m/m) % for LLP events [3]. The linear range should be expressed in either 
GMO mass fractions or copy number ratios, while stating clearly which measurement unit 
 
17
has been used. Mass fractions can be expressed as g/kg or as a percentage (g/100 g). 
Preferably copy number ratios are also expressed as a percentage.  
 
Note: The linear range mentioned above is called the ‘dynamic range’ and is defined as the 
range of concentrations for which the method has with an acceptable level of trueness and 
precision a linear relation between the logarithm of the concentrations and the Cq values. The 
decadic logarithm of the concentration is plotted against and the Cq values to generate a 
calibration curve. 
 
Acceptance criterion for R2 coefficient: The recommended average value of R2 shall be ≥ 
0.98. 
 
Acceptance criterion for amplification efficiency: For quantitative methods, the 
recommended average value of the slope of the calibration curve shall be in the range of  –3.1 
and –3.6 [7].  
5.2.1.7 Trueness 
 
Procedure: The trueness should be determined at a level close to the level of decisions 
(typically the legal labelling threshold of 0.9 % for authorised events [2] or 0.1 (m/m) % for 
LLP events [3]), preferably also at the LOQ level [7]. Any bias detected needs to be 
eliminated or corrected (Section 5.2.2.3) in order not to hamper the trueness of the obtained 
measurement results. 
 
Acceptance criterion: If no significant difference is observed between the measurement 
results obtained on the CRM and the certified value, considering both uncertainties, the 
trueness of the method is confirmed [16]. 
 
If no CRM is available for the proper concentration additional steps need to be taken (Section 
7.2). Alternatively the outcome achieved by a laboratory within a PT can be used to verify if 
the reported value is in agreement with the consensus value. Acceptance criterion: A z-score 
and a zeta-score between 2 and -2 can be considered as satisfactory. 
Note: The interpretation of z-scores alone needs to be handled with care as the consensus 
value may differ from the true value. For the evaluation of the PT outcome the expected GM 
level (e.g. from the spiking of the PT sample) should be taken into account. 
5.2.1.8 Relative repeatability standard deviation 
 
Procedure: The relative repeatability standard deviation (RSDr) can be determined in a way 
similar to that described under trueness (Section 5.2.1.7). It is calculated from PCR replicates 
run under repeatability conditions. Repeatability should be investigated for different GM 
concentrations using the same procedure and instrument under the same conditions within a 
short period of time. 
 
The testing conditions (reaction volume, PCR machine, number of extractions and number of 
PCR replicates, etc.) should be the same as those during routine analysis of samples. Results 
from at least 16 PCR replicates should be obtained. Examples for possible test designs can be 
found elsewhere [7]. 
Acceptance criterion: RSDr should be ≤ 25 % (calculated on the measured GMO content), 
over the dynamic range of the method. 
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5.2.1.9 Limit of detection 
 
Procedure: A positive control material of low GM concentration can be measured in 10 PCR 
replicates, and if all replicates are positive, this infers that the LOD is with a 95 % confidence 
level below or equal to the positive control material concentration. One possible way of 
calculating the LOD is given in [17], an alternative is outlined in [7]. 
 
Acceptance criterion: Whenever validation data are available the LOD should be in line with 
those data [7]. 
 
Note: During method verification the laboratory established the LOD with a certain 
confidence level, usually an LOD with 95 % confidence interval is calculated. This LOD and 
its confidence level is based on the number of measurements.  During the routine application 
of qPCR less than 10 (usually 2 to 3 measurements) are performed.  As qPCR ideally detects 
each single amplifiable molecule in the reaction tube, a discrepancy can sometimes be 
observed between the results obtained during LOD establishment and during routine analysis.  
 
The reason for this discrepancy is that 2 to 3 positive measurement results may be observed 
even at this confidence level of 30 %. 
5.2.1.10 Limit of quantification  
 
Procedure: A positive control material of, for example, 0.1 (m/m) % can be analysed in 10 
PCR replicates of the GM target and 10 replicates of the taxon-specific gene target. The RSDr 
at the LOQ should be below 25 % (calculated on the measured GMO content). To establish 
the true LOQ, it would be necessary to make dilutions to a lower GM content (for further 
guidance see [7]). Besides the RSDr established at the LOQ, the trueness of the measurement 
should be verified during method verification (Section 5.2.1.7). 
 
Acceptance criterion: Whenever validation data are available, the LOQ should be in line with 
(or better than) those data [7]. 
 
Note: By establishing the LOQ on 10 PCR replicates derived from the same DNA extract, the 
potential effect of the DNA extraction method is not covered. 
 
To ensure that the DNA concentration has not been overestimated, a test could be performed. 
A nominal dilution of 0.1 copy per PCR reaction is tested in six replicates. No more than one 
out of the six replicates should create a positive measurement signal [7]. 
5.2.2 Measurement uncertainty estimation 
 
Measurement uncertainty (MU) is estimated using data obtained on samples within a given 
laboratory, establishing the within-laboratory reproducibility. There are different possibilities 
to establish the within-laboratory reproducibility, one option is to use the data generated 
during method verification [7]. Another option is using data obtained on laboratory samples 
(such as internal quality control data). The accessibility of samples might influence which 
approach is to be used.  
GMO laboratories may also use information derived from the following procedures to aid 
their estimation of the uncertainty of measurement results: 
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• the ISO/IEC Guide 98: Guide to expression of uncertainty in measurement [18] 
• the EURACHEM/CITAC Guide: Guide to quantifying uncertainty in analytical 
measurement [19]. 
 
The possibility to use data obtained on routine samples has been outlined, together with other 
options, in the Guidance Document on Measurement Uncertainty for GMO Testing 
Laboratories [17]. In this document worked-out examples are provided. The general 
approach is to estimate the within-laboratory reproducibility (measurement variation) using 
the repeated independent analyses of a range of real samples and add the uncertainty 
connected to the bias control. This general approach is valid as long as no significant 
measurement bias has been found during the bias control and is based on the Nordtest report 
[20] and outlined in Sections 5.2.2.1 to 5.2.2.6 of this document. 
 
Note: MU estimation is independent from the unit of measurement (being either mass 
fractions (m/m) or copy number ratios) and is carried out in the same way for either unit of 
measurement. 
 
MU is a single parameter that describes the quality of measurement and is linked to the 
individual measurement performed and each laboratory has to evaluate the specific MU for a 
measurement result obtained under defined conditions. 
 
MU should take into account all effects on a measurement process. If sampling is outside the 
control of the testing laboratory, and it is considered as a meaningful component in the MU 
budget, it should explicitly be stated that the uncertainty budget does not cover the sampling 
uncertainty. 
 
A control laboratory shall always estimate [1] and should report the MU associated with their 
analytical results. 
 
5.2.2.1 Within-laboratory reproducibility 
 
The general approach is to estimate the within-laboratory reproducibility and to determine it 
by repeated independent analysis of samples in analytical runs that represent the long-term 
variation of analytical components within the laboratory, e.g. different operators, stock 
solutions, new batches of critical reagents, recalibrations of equipment, etc. Also, samples 
should represent the different matrices and concentrations to which the estimates of MU will 
be applied. In particular, samples with a GMO content close to the thresholds against which 
results will be compared should be included (which is typically the legal labelling threshold 
of 0.9 % for authorised events [2] or 0.1 (m/m) % for LLP events [3]). MU estimates should 
be updated by the addition of new results. 
 
Repeated independent results produced on at least 15 samples should be used (N ≥ 15). In 
order to maximise the matrices and concentrations studied it is recommended that the 
smallest replication e.g. two independent measurements (n = 2) per sample (two extractions 
from the same sample), is applied to the largest number of samples possible.  
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The absolute within-laboratory reproducibility standard deviation (sR) is calculated from the 
six results with the lowest mean concentration (N = 6, n = 2). As this standard deviation is 
derived from duplicate analysis, it gives only a repeatability component and needs to be 
combined with further data from samples analysed independently. The remaining samples (N 
≥ 9, n = 2) are used to calculate a relative within-laboratory reproducibility standard deviation 
(RSDR). In this way the repeatability component will be included twice, but is normally still 
small in comparison to the between-day variation. For further details see [20]. 
 
5.2.2.2 Absolute and relative within-laboratory reproducibility 
 
The mean ( ic ) of two independent analytical results is calculated as: 
2
2,1, ii
i
ccc +=     Equation 1 
ic  mean of two analytical results 
1,ic  result of first analysis of sample i 
2,ic  result of second analysis of sample i 
 
The absolute difference ( id ) between the first and the second analysis is calculated as: 
 
2,1, iii ccd −=     Equation 2 
 
id  absolute difference between two analytical results 
1,ic  result of first analysis of sample i 
2,ic  result of second analysis of sample i 
 
The relative difference between analyses (radi) is calculated in per cent as: 
 
100
i
ii c
drad =     Equation 3 
 
radi relative difference 
id  absolute difference between two analytical results 
ic  mean of two analytical results 
 
 
Given a set of differences and relative differences calculated from the analysis of a number of 
samples (N ≥ 15, n = 2) the average difference ( d ) and average relative difference ( rad ) can 
be calculated. 
 
The absolute within-laboratory reproducibility standard deviation (sR) in the case of two 
independent measurements results (n = 2) is estimated via: 
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13.12
d
d
ds ==R     Equation 4 
 
d  average absolute difference 
sR absolute within-laboratory reproducibility standard deviation 
d2 1.13 (rounded constant depending on the number of independent measurements (n) [xx]) 
 
 
The relative within-laboratory reproducibility standard deviation (RSDR) is given by: 
 
13.1
radRSDR =      Equation 5 
 
RSDR relative within-laboratory reproducibility 
rad  average relative difference 
 
5.2.2.3 Bias control 
 
A CRM with its certified value and uncertainty should be used for the bias control. After the 
measurement of a CRM the absolute difference between the mean measured value and the 
certified value can be calculated as: 
CRMmm cc −=Δ     Equation 6 
Δm  absolute difference between mean measured value and certified value 
cm   mean measured value 
cCRM certified value 
 
The uncertainty of Δm is uΔ, which is calculated from the uncertainty of the certified value 
and the uncertainty of the measurement result. 
 
The uncertainty of the measurement result (um) can be estimated by dividing the standard 
deviation by the square root of the number of measurements carried out: 
n
su mm =      Equation 7 
 
um standard uncertainty of the measurement result 
sm standard deviation of the measurement result 
n number of independent measurement results 
 
The expanded uncertainties UCRM of each certified value are given on the CRM certificate. 
The standard uncertainty, uCRM, of the certified value is obtained by dividing the stated 
expanded uncertainty by the coverage factor given on the certificate. 
 
The combined standard uncertainty (uΔ) of measurement result and certified value is 
calculated according to: 
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2
CRM
2
m uuu +=Δ     Equation 8 
uΔ combined standard uncertainty of the measurement result and certified value (= uncertainty of 
Δm: absolute difference between mean measured value and certified value, Equation 6) 
um standard uncertainty of the measurement result 
uCRM standard uncertainty of the certified value 
Note: In case of asymmetric uncertainties of the certified value, the uncertainty concerned 
has to be taken. For example, if the measured value is above the certified value the 'plus' 
uncertainty of the certified value has to be taken. 
The expanded uncertainty UΔ, corresponding to a confidence level of approximately 95 %, is 
obtained by multiplication of uΔ by a coverage factor k = 2. 
 
ΔΔ uU ×= 2      Equation 9 
UΔ expanded uncertainty of difference between result and certified value 
uΔ combined standard uncertainty of the measurement result and certified value 
Note: For most purposes it is recommended that a coverage factor of k = 2 is used as the 
statistical observations have a degree of freedom of at least 6 [19]. 
 
If Δm (= the absolute difference between the mean measured value and the certified value) is 
smaller or less than UΔ (= the expanded uncertainty of the difference between results and 
certified value), then there is no significant difference between the measurement result and 
the certified value, meaning that the method does not have a bias. In case a bias is found, the 
cause has to be investigated and preferably eliminated. Approaches to calculate a bias can be 
found in the Guide to the expression of uncertainty in measurements (GUM) [19], but have to 
be considered carefully as a bias may be a constant or may be proportional to the measured 
GM concentration. 
 
In the case that no CRM with the required concentration level is available for bias control, 
CRMs certified for their GM purity can be used. The standard uncertainty of a sample 
produced by the laboratory has to be estimated using also the purity data of the CRMs used. 
 
Example: 
No CRM with the required GM concentration level is available and a sample with 10 g/kg (or 
1 (m/m) %) GM content has to be produced by the laboratory using available CRMs certified 
for their GM purity. The laboratory has to estimate the standard uncertainty for the sample 
produced. 
 
The available CRMs certified for their purity are: 
• pure GM material certified to contain with 95 % probability > 985 g/kg (or 
98.5 (m/m) %) of the GM event; 
• a non-GM material certified to contain with 95 % probability < 1 g/kg (or 
0.1 (m/m) %) of the GM event. 
 
The required sample will be weighed at mass level of the powders using an analytical 
balance. The example given here refers to the weighing of 0.01 g of GM powder and 0.99 g 
of the non-GM powder. The nominal or target value of the mixture produced by the 
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laboratory is 1 (m/m) % GM (0.01 g / (0.99 + 0.01) g). The denominator is composed of 
0.99 g non-GM material and 0.01 g GM material. 
 
In order to avoid the introduction of a bias due to different water contents of the GM and 
non-GM material, it is recommended to equilibrate the water content of both powders for 
24  h (spread the powder on a dish and expose to the air in the laboratory).  
Four standard uncertainty sources have to be considered: 
• uncertainty arising from the purity of the non-GM material,  
• uncertainty arising from the purity of the GM material,  
• uncertainty arising from the weighing of the non-GM material and 
• uncertainty arising from the weighing of the GM material. 
 
The uncertainty of the GM and non-GM material purity is taken from the certificate. In this 
example the standard uncertainty arising from the purity of the GM material is 1.5 % (100 % 
- 98.5 % = 1.5 %) and 0.1 % for the non-GM material. The accredited calibration service 
reported for the used analytical balance a standard uncertainty of 1.3 %. This uncertainty 
contributes to the combined standard uncertainty during each weighing step. The combined 
uncertainty is calculated by taking the square root of the sum of the individual standard 
uncertainties: 
2
)2(
2
)1(
2
)2(
2
)1( wwpp uuuuu +++=    Equation 10 
u combined standard uncertainty  
up(1) standard uncertainty related to the purity of the non-GM material 
up(2) standard uncertainty related to the purity of the GM material 
uw(1) standard uncertainty related to the weighing of the non-GM material 
uw(2) standard uncertainty related to the weighing of the GM material 
 
 
              0.013)  g (0.01 + 0.013)  g (0.99 + 0.001)  g (0.01 + 0.015)  g (0.99 2222 ××××=u  
 
The combined standard uncertainty is calculated to be 0.12955 g. 
The real GM value of the produced sample and its rounded standard uncertainty is estimated 
to be: 
1.00 ± 0.13 g/kg  
 
Note: The above calculations concern standard uncertainties as required for bias control. If 
expanded uncertainties are required, the obtained uncertainties have to be multiplied with the 
appropriate coverage factor [18]. 
 
Likewise, attention has to be paid to the DNA extraction step. As further outlined in Section 
7.2.3 a co-extraction procedure should be applied in order to avoid the need for a mixing step 
at powder level, which could easily lead to non-sufficiently homogeneous samples. 
In case only intact seed CRMs are available, it is advised to crush the GM and non-GM seeds 
separately in mortars and to allow them to equilibrate to the same water content for 24 h. 
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5.2.2.4 Estimation of the uncertainty component associated with bias 
 
The relative standard uncertainty associated with the bias (ubiasr) is given by: 
22
100⎟⎟⎠
⎞
⎜⎜⎝
⎛+=
CRM
CRMRbiasr c
u
n
RSDu   Equation 11 
RSDR relative within-laboratory reproducibility 
n number of measurements 
uCRM standard uncertainty associated with the certified value of the CRM 
cCRM certified value of the CRM 
 
Note: In case of a bias the experimental set-up should be changed until no bias is found. If the 
bias cannot be eliminated the approach described here, of only adding the uncertainty related 
to the bias control (ubiasr), is not sufficient. In case that the bias is not eliminated, which is 
generally not recommended, the bias needs to be added additionally to the uncertainty 
estimation. For further information see [19]. 
5.2.2.5 Calculation of the relative standard uncertainty 
 
The relative standard uncertainty (RSU) is calculated by combining the relative within-
laboratory reproducibility standard deviation (RSDR) and relative uncertainty associated with 
bias (ubiasr) using: 
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biasrR uRSDRSU +=    Equation 12 
RSDR relative within-laboratory reproducibility 
ubiasr  standard uncertainty associated with biasr 
 
Note: The individual standard uncertainties need to have the format of a standard deviation in 
order to allow summing up. Independent uncertainties can be combined by taking the square 
root of the sum of the individual squares [19]. RSU and ubiasr are not completely independent 
from each other as all measurements are influenced by the RSDR (equations 11 and 12). The 
effect of taking RSDR twice into account for the uncertainty estimation is considered to be 
negligible. 
5.2.2.6 Evaluation of measurement uncertainty 
 
The uncertainty contributions are assumed to be composed of a constant contribution and a 
contribution proportional to the measured concentration c. Both can be estimated from 
within-laboratory reproducibility data obtained on within-laboratory samples. For the 
absolute standard uncertainty (u0) sR can be used (equation 4) and for the relative standard 
uncertainty (RSU) equation 12 can be used. The standard uncertainty u associated with a 
measurement result c is given by: 
 
( )220 RSUcuu ×+=    Equation 13 
uo  absolute standard uncertainty 
c  measurement result 
RSU  relative standard uncertainty 
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Note: It has to be stressed that equation 13 is valid under the assumption that u0 is constant 
and RSU is proportional to the GM concentration c. This assumption should be checked using 
in-house validation or verification data. 
It can occur that u0 is so small that it can be neglected. 
 
Regulations (EC) No 1829/2003 [2] and (EC) No 1830/2003 [21] set a labelling threshold for 
the total authorised GMO presence on an ingredient basis. As such, the GMO contents for 
various events of one ingredient must be added together and the uncertainties associated with 
each individual GMO measurement combined. The MU of various methods can be combined 
by adding the squares and taking the square root of the sum: 
 
∑ == ni imethc uu ,1 2 ,     Equation 14 
 
uc  combined standard uncertainty associated with the measurement result for one ingredient 
n  number of methods applied 
umeth,i  absolute standard uncertainty of individual method 
 
The expanded uncertainty U (giving a confidence level of approximately 95 %) is given by: 
 
cuU ×= 2      Equation 15 
uc  combined standard uncertainty associated with the measurement result for one ingredient 
 
6 Measurement unit for GMO quantities — ISO/IEC 17025, Section 5.6.2.2.1 
 
The measurement signals of qPCR are Cq (quantification cycles), which correspond to the 
number of amplification cycles a DNA extract has to undergo in order to pass a set 
fluorescence detection threshold. The Cq value has an inverse correlation with the number of 
amplifiable DNA targets in the extract. But there is no simple and theoretically predictable 
correlation between the number of initial DNA targets and the Cq measured by qPCR. As 
various reaction conditions of qPCR and potential matrix effects influence the measured Cq, 
knowledge about the genetic composition of the plant material does not allow to predict the 
measurement results. In order to translate the Cq obtained for DNA extracted from an 
unknown sample into a measurement result, calibration of the qPCR signals is required. The 
calibration determines whether the measurement result is expressed in GM mass fractions or 
in GM-DNA copy numbers relative to target taxon-specific DNA copy numbers calculated in 
terms of haploid genomes. 
 
Measurement results of GM food and feed samples can be expressed as a percentage and 
would be either mass fractions or GM DNA in relation to total species DNA. In both cases 
the measured GM content is expressed relative (either relative to the mass of the species or 
relative to the taxon-specific gene content). 
 
The intended calibration approaches described in the following are meant to be used together 
with the EURL-GMFF validated qPCR methods. 
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6.1 Calibration of qPCR measurements for results expressed in mass fractions 
 
For all GM events authorised in the European Union, CRMs are available which are either 
certified for a GM mass fraction or for their mass-related purity (nominal 0 and 100 % GMO 
CRMs). 
6.1.1 Calibration with CRMs providing values for various mass fractions 
 
CRMs certified for different GM mass fraction are used to extract DNA and to set up two 
calibration curves: one for the transgene and one for the taxon-specific gene. Each mass 
fraction CRM leads in this case to a point on each calibration curve. Using the CRMs in this 
way ensures that dilution does not eliminate possible matrix effects of food and feed samples. 
 
The other approach often applied, namely to extract DNA from the CRM containing the 
highest concentration of the GM event and to dilute the extracted DNA to set up the two 
calibration curves, requires a further quality control to check for possible matrix effects 
(Section 7.4). 
 
It is important to set up both calibration curves from the same DNA extract and individual 
extracts need to be pooled beforehand. By ensuring this, possible mistakes related to DNA 
quantity measurements are equalled out (e.g. an overestimated DNA quantity would be 
equally overestimated for the transgene and taxon-specific calibration curves). 
 
Using the certified value of the CRM and taking the dilution factors including their 
uncertainties into account, the transgene calibration curve allows conversion of the measured 
Cq for the transgene in an unknown sample into a GM mass and the taxon-specific gene 
calibration curve allows conversion of the measured Cq for the taxon-specific in an unknown 
sample into the total species mass. The ratio of both gives the GM mass fraction. 
 
Note: In both cases of setting up a calibration curve, a minimum of 5 calibration points 
should be used per calibration curve [7]. 
 
6.1.2 Calibration in mass fractions with pure GM CRMs 
 
DNA is extracted from the CRM containing pure GM material and is diluted to set up the two 
calibration curves: one for the transgene and one for the taxon-specific gene. Afterwards the 
ratio of both is obtained as described in Section 6.1.1. 
A further quality control check for potential matrix effects is required (Section 7.2.1 or 7.2.2). 
6.2 Calibration of qPCR measurement results expressed in GM DNA copy 
number ratios 
 
For a few GM events authorised in the EU, CRMs for calibration of measurements expressed 
in haploid genome ratios are available.  
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Note: With respect to many plants, which are polyploid in the mitotic phase (sporophyte), the 
haploid genome would still represent more than one genome equivalent in the meiotic phase 
(gametophyte). Thus, the term 'haploid' might be misleading and should be understood in this 
context as 'holoploid' (for further information see [22]). 
6.2.1 Calibration in haploid genome ratios with available CRMs  
 
A plasmid CRM containing both the transgenic and the taxon-specific DNA fragments, 
certified for its DNA sequence and suitable for calibration is used for setting up the two 
required calibration curves. The various calibration points are achieved by dilution of the 
same plasmid solution. More details can be found in [23]. 
Note: In both cases of setting up a calibration curve, a minimum of 5 calibration points 
should be used per calibration curve [7]. 
6.2.2 Calibration in haploid genome ratios in the absence of CRMs 
 
In the absence of a CRM for calibration, a plasmid containing the two targets (transgene and 
taxon-specific gene) in a known ratio can be used. Care has to be taken that the purity of the 
plasmid can be guaranteed (no contamination e.g. with plasmids containing a different 
number or ratio of the two targets) and that the plasmid is suitable for PCR amplification 
(identical efficiency of the targets during amplification). Information about the suitability 
check for calibration can be found in [24]. 
6.3 Additional notes 
 
(a) Calibration processes are linked to an uncertainty. In general, the uncertainty of the 
calibration process has to be added. To cover the reproducibility of the calibration, it is 
recommendable to carry out several calibrations during the method application or 
verification. Use of these values to estimate the MU linked to the GMO quantification 
measurements ensures that the uncertainty covers the reproducibility of the calibration curve. 
In case of a mass fraction certified CRM the uncertainty of the calibrant is given by the 
certified value and its expanded uncertainty. For the certified plasmid calibrants the 
uncertainty has been found to be negligible. However, even for the mass fraction CRMs the 
uncertainty is often less than one third of the uncertainty arising from the reproducibility of 
the qPCR method and can therefore, using the GUM approach [19], be neglected. A careful 
evaluation of the uncertainty linked to the calibration process is strongly recommended. In 
particular the non-equivalence of plasmid and genomic DNA in the PCR process has to be 
considered. 
 
(b) The conversion from measurement results expressed in mass fractions into measurement 
results expressed in haploid genome copy number ratios is connected with a huge 
uncertainty, which leads often to meaningless results as discrimination from zero is not 
possible anymore, for details see [25]. 
 
(c) Also the mass fraction based reference system is artificial, as qPCR quantifies DNA 
targets. As these DNA targets are not necessarily equally present (and accessible) in different 
samples of the same mass with the same GM event or species identity, the CRM and the 
qPCR methods set the reference system and therefore should be specified when reporting the 
measurement results. One should be aware that also the use of several CRMs with different 
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mass fractions for the calibration curve compared to one CRM (dilution of the extracted 
DNA) influences the reference system. In the first case the reference system is based on the 
two varieties used as GM and non-GM components in the CRMs: in the second case the 
reference system is based on the variety used as GM material. 
 
(d) The application of the ΔCq method is generally not recommended (but might need to be 
applied when the validated method is a ΔCq method). The ΔCq method uses one calibration 
curve for the ratio of transgenic and taxon-specific DNA fragments and depends on identical 
efficiencies of the PCR amplification of transgene and taxon-specific target genes, which is 
often not realised. The ∆Cq method can be used if satisfactory validation and verification 
data show that the PCR amplification efficiencies on both, the transgenic target and the 
taxon-specific target are not significantly different from each other. In this case DNA is 
extracted from various CRMs and used to establish the required calibration curve.  
 
7 Selection and use of reference material — ISO/IEC 17025, Section 5.6.3 
 
CRMs with certified values traceable to SI Units of measurement shall be used when 
available [1]. The quality control with a CRM verifies if a correct measurement procedure 
(including calibration) has been carried out and if the measurement results obtained on 
routine samples can be trusted. Only CRMs certified for their GM content expressed in the 
same measurement unit as the one established during calibration can be used for a 
meaningful quality control. 
 
7.1 Quality control with CRM available with the adequate GM concentration 
 
A different CRM from the one used for setting up the calibration curves is used for quality 
control of the measurement system. This CRM is treated like an unknown sample and 
analysed using the two calibration curves. The measured value and its standard deviation 
should be compared to the certified value and its uncertainty as outlined in Section 5.2.2.3 
[16]. 
 
When using such a matrix CRM for verification, the uncertainty derived from the verification 
data covers the uncertainty related to the extraction step.  
 
For measurements calibrated in haploid genome ratios the matrix CRM certified for its 
haploid genome ratio is used for quality control. This CRM is treated as an unknown sample 
and analysed using the two calibration curves established with the independent calibrant. 
Note: CRMs certified for their GM concentration in haploid genome ratios are only available 
for a few GM events. 
7.2 Quality control with CRM materials mixed in the laboratory 
Some of the CRMs are not available in the desired GM concentrations and the laboratory 
may need to produce other GM concentration, e.g. for determining the LOQ and LOD or to 
have a quality control material close to the GM concentration of interest. 
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Four situations in which additional GM concentration levels need to be produced by the 
laboratory can arise: 
• the GM and non GM CRMs are only available as pure seed materials (Section 
7.2.1); 
• the GM and non GM CRMs are only available as pure powder materials (Section 
7.2.2); 
• the mixed GM CRMs are only available with inadequate GM concentrations 
(Section 7.2.3); 
• the GM and non GM CRMs are only available as extracted DNA solutions 
(Section 7.2.4). 
 
7.2.1 GM and non-GM CRMs available as pure seed materials  
 
As the material is certified to be pure non-GM and pure GM material, respectively, no 
homogeneity issues need to be considered for the CRM and a lower sample intake than the 
minimum sample intake recommended for analysis can be used. Two possible ways are 
proposed: 
 
7.2.1.1 Mixing at seed level 
 
Provided the average mass weight of the seeds is similar, the seeds are counted and mixed to 
achieve the desired composition (1 GM seed with 1999 non-GM seeds for a 0.05 (m/m) %). 
The whole sample is first ground in a blender. After that, the powder is ground in a mortar to 
achieve a homogeneous material.  
Note: This approach is only feasible for small seeds. Attention should be paid to the fact that 
GM seed batches may contain with a certain (low) probability non-GM seeds. However, 
grinding of the samples may lead to different particle sizes or larger particle sizes than 
required. In this case mixing at DNA level and control of matrix effects by spiking into a 
non-GMO extract is recommended (Section 7.2.1.2). 
 
7.2.1.2 Mixing at DNA level 
 
As stipulated in [7] separate portions of non-GM seeds and GM seeds are ground, and the 
DNA extracted separately from both. The content of the taxon-specific gene for the GM 
positive and a GM negative DNA extract should be measured on the same plate with the 
same calibration curve. Following this, the dilution factor for the two DNA preparations can 
be calculated using the following formula: 
X = (A/B) x (Y– 1) + 1     Equation 16 
X = the dilution factor (dilution needed to take into account the different content of the taxon-specific 
gene in solutions A and B) 
A = copy number of the taxon-specific gene for the GM positive DNA preparation 
B = copy number of the taxon-specific gene for the GM negative DNA preparation 
Y = the theoretical dilution factor e.g. from 10 % GM to 1 % GM = 10x 
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Example: 
Solution A is DNA extracted from a pure GM material (nominal 100 (m/m) % GM) and 
solution B is extracted from a non-GM material (nominal 0 (m/m) % GM). A volume of 5 µL 
of both solutions is measured by PCR and the relative quantity of the taxon-specific gene 
determined. As the taxon-specific gene quantity is determined relatively only limited 
information about the theoretical copy numbers, the average genome size and the zygosity is 
needed. The theoretical copy number should be estimated to avoid that a sample contains less 
than 30 copies. 
 
The quantification of the taxon-specific gene gives for example 1000 copies/5 µL for solution 
A and 800 copies/5 µL for solution B. Aiming at a dilution factor of 10 (and a nominal 
concentration of 10 (m/m) % GM), the dilution of solution A with solution B can be 
calculated using equation 16: 
 
X: (1000/800) x (10– 1) + 1 = 12.25, so 1 µL A has to be mixed with 11.25 µL B. For 
practical reasons it is advisable to mix e.g. 100 µL of solution A with 1125 µL of solution B. 
 
After adding together the two DNA preparations, the DNA solution has to be mixed 
thoroughly. 
 
The mixtures can be used to test the correctness of a measurement result using the diluted 
extract from a pure GM material and analysing three samples in triplicate, on three different 
days. 
7.2.2 GM and non-GM CRMs available as pure powder materials  
 
As the materials are certified to be pure non-GM and pure GM material, respectively, mixing 
at powder level is feasible. No homogeneity issues need to be considered for the CRM and a 
lower sample intake than the minimum sample intake stated on the certificate can be used. 
Furthermore, the materials have been ground using industrial mills which lead to particles 
sizes that allow weighing of samples in the mg range without the introduction of too high 
scatter. 
It should be noted that the total DNA content in the pure GM and non-GM material should 
not be significantly different. This is normally investigated by the CRM producer and 
reported in the certification report. Additionally, care must be taken that the extraction 
method employed does not introduce a bias. This is of utmost importance in cases where the 
composition of the GM material has been altered by the genetic modification (e.g. starch 
modified potatoes).  
Example: 
To get a 1 (m/m) % GM mixture from a nominal 100 % GM powder CRM and a nominal 
0 % powder CRM, one should use an analytical balance weighing 990 mg of non GM powder 
and 10 mg of GM powder. The DNA should be extracted from the combined materials using 
a suitable extraction method from the whole 1000 mg sample, avoiding the need to mix the 
powder samples homogenously. 
 
A way to estimate the uncertainty related to such a CRM produced by the laboratory is 
outlined in the example in Section 5.2.2.3. Smaller samples can be used to produce a sample, 
but will be linked to higher uncertainty contributions from the weighing step.  
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Alternatively, the approach as outlined in Section 7.2.1.2 can be used for mixtures at DNA 
level. 
7.2.3 Mixed GM CRMs available as powder materials with inadequate GM 
concentrations  
 
The powders can be used in a co-extraction procedure. As the CRMs are certified GM 
mixtures homogeneity issues need to be considered and the minimum sample intake has to be 
respected. In the co-extraction procedure the required amounts of two CRM powders are 
weighed (using individual minimum weights equal to or above the minimum sample intake), 
combined and extracted as one DNA extraction sample. Mixing of the powders should not be 
done as homogeneity cannot be guaranteed. 
It should be noted that the total DNA content in the pure GM and non-GM material should 
not be significantly different. Furthermore, the particle sizes of the non-GM and GM material 
should not be significantly different as this otherwise introduces a bias on the amount of 
DNA extracted. These two parameters are normally investigated by the CRM producer and 
described in the certification report. Additional care must be taken by the laboratory that the 
extraction method employed does not introduce a bias. This is of utmost importance in cases 
where the composition of the GM material has been altered by the genetic modification (e.g. 
starch-modified potatoes). 
Example: 
To get a 1 (m/m) % material while having a 2 (m/m) % and a nominal 0 (m/m)  % material, 
one can co-extract from the combination of the same amount of both materials the DNA. If 
the minimum sample intake is 100 mg for both materials, the final sample will be 200 mg 
from which DNA needs to be extracted using a suitable DNA extraction method. 
The uncertainty of the GM content of the resulting material is the combined uncertainty of 
the values stated for the two CRMs used.  
 
Alternatively the approach as outlined in Section 7.2.1.2 can be used for mixtures at DNA 
level.  
 
7.2.4 GM and non-GM CRMs available as extracted pure DNA solutions 
 
Mixing is required at DNA level to achieve the desired test concentrations. 
The example given in Section 7.2.1.2 can be followed. 
 
The estimation of the related uncertainty follows the example given for a mass-based mixture 
in Section 5.2.2.3. 
7.3 Additional notes 
 
(a) For measurements calibrated in mass fractions only one set of CRMs is available. The 
quality control of measurements expressed in mass fraction is usually limited as the materials 
used for calibration and quality control are derived from the same batch of CRMs. It is 
therefore recommended to use the CRM certified for the highest GM concentration for setting 
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up the calibration curve and to use a CRM certified for a lower concentration for quality 
control or to follow the example given in Section 5.2.2.3. However, the user must be aware 
that the measurement process cannot be fully controlled in this way. 
 
(b) The use of extracted DNA solutions as CRM for quality control does not cover the DNA 
extraction step. Checking for matrix effects by spiking into an extract from non-GM material 
is required. It might be difficult to source a non-GM material which is proven to be 
completely free of GMOs. However, CRMs certified not to contain a specific GM event 
could be used to set up a systematic check. 
 
(c) For quality control, also materials analysed and shared by various laboratories could be 
considered. However, special care has to be taken by the user that the material is sufficiently 
homogenous and stable. 
 
8 Measurement traceability and monitoring of key equipment and methods — 
ISO/IEC 17025, Sections 5.5.2, 5.6.1 and 5.9.2 
 
All equipment used within the scope of accreditation and whose accuracy may significantly 
affect the accuracy or validity of the test result shall be calibrated by a laboratory competent 
for the task. It is up to individual laboratories to provide formal documented assurance that 
the requirements for calibration have been met. A competent calibration laboratory may be a 
laboratory accredited for the specific task by the national accreditation body or by an 
accreditation body of a country which is a signatory to the European Accreditation 
Multilateral Agreement. All calibration certificates issued by an accredited laboratory will 
contain a statement about traceability of the measurement result, including uncertainty and 
confidence levels. 
 
Non-accredited calibration laboratories may be used whenever such an option is inevitable.  
 
However, the selected laboratory has to prove its competence. Alternatively, and provided 
that the appropriate technical competence is available within the organisation, it can calibrate 
its own equipment internally. In such cases, laboratories must develop detailed calibration 
procedures including estimations on the measurement uncertainties associated with these 
calibrations. 
 
It should be noted that metrological traceability is also checked by the use of CRMs (Section 
7). 
 
For GMO laboratories there are three key pieces of equipment to monitor: balances, thermal 
cyclers and microlitre pipettes (MPs) [26]. 
8.1 Thermal cycler check 
8.1.1 Maintenance 
 
Maintenance should be carried out on an annual basis. The maintenance needs to include: 
cleaning, background testing, general checks and other specific checks depending on the 
equipment used. Software updates should be considered if recommended by the 
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manufacturer. After completion of the maintenance it is advisable to analyse an internal 
quality control sample. 
Note: Typically full instrument maintenance is performed by an external company on an 
annual basis. Specific maintenance procedures are carried out by the laboratory itself with 
higher frequencies. 
8.1.2 Inspection of the performance of the PCR wells 
 
Inspection of equal amplification and detection across the PCR wells should be carried out at 
least once per year or after a certain number of PCR runs. The procedure can be the 
following: a master mix which contains a DNA target is divided up among all wells in order 
to have approximately 1000 copies of DNA targets per well (a linearised plasmid can for 
instance be used in conjunction with a dedicated PCR method). 
 
The measured Cq values are imported into an Excel sheet and theoretical copy numbers 
which should obtained in each well are calculated, taking the number of PCR cycles into 
account and assuming 100 % PCR efficiency. Mean, standard deviation (s) and RSD (RSD 
[%] = s / mean x 100 %) are calculated for each well. 
 
For acceptance, the RSD must be less than or equal to 25 %. The deviation from the mean is 
determined for each well. It must be less than or equal to 25 %. 
If any of the criteria are not fulfilled, a second test is carried out. 
 
Note: Commercial tests can also be used to verify the performance of all PCR wells. In cases 
of doubt they could be compared with the outcome of an inspection carried out as outline 
before. 
 
The described inspection is carried out on an annual basis or depending on the number of 
PCR runs. However, this inspection cannot replace the controls used on each PCR plate. 
8.1.3 Background testing and cleaning of the PCR instrument 
 
Background testing and cleaning of the parts in direct contact with the PCR wells (e.g. 
thermal block or chamber including the rotor) needs to be carried out in regular intervals 
taking into account the manufacturer’s instructions.  
 
The background test is performed according to manufacturer’s instructions (e.g. fluorescence 
measurement for 2 min at 60 °C of a plate containing 50 µl of ultrapure water per well). 
8.1.4 Specific checks 
 
Specific checks need to be carried out and manufacturer’s instructions have to be considered. 
It is up to the laboratory to define if the specific checks are carried out by an external 
company or by the laboratory itself. They should be carried out in regular intervals taking 
into account the frequency of use.  
 
The specific check can for instance concern a calibration using a dedicated pre-filled plate, 
allowing the software to map the position of the wells so that, during instrument operation, 
the software can associate increases in fluorescence with specific wells. The halogen lamps 
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should also be checked in accordance with the manufacturer’s instructions and depending on 
the number of PCR runs performed on the device. 
A temperature drift monitoring system for thermal cyclers can also be used as periodic 
validation of the PCR instrument. The accuracy and non-uniformity of the temperature in a 
PCR cycler are then measured. 
8.2 Microlitre pipette control 
 
Each MP needs to be clearly labelled, located and dedicated to a specific use. MPs shall be 
checked and/or calibrated before use [1, Section 5.5.2]. 
Inspections are carried out depending on the use and the volume of the MP. They can be 
based on ISO 8655 [27] and ISO 4787 [28]. 
 
MPs should be calibrated at least once a year either by the laboratory or by an external 
calibration service. For internal checking of volumes of less than 50 µL a five-digit balance is 
required. A balance connected with software for equipment validation can be used. For 
example, the check can consist of 10 repetitions at three different levels (e.g. 20, 100 and 200 
µL for an MP with an upper volume of 200 µL). The software calculates trueness and 
repeatability, and indicates the acceptance limits. 
 
It is up to individual laboratories to define the frequency of the MP control. 
8.3 Internal quality control 
 
The selection of internal quality control samples, frequency of use and reporting in quality 
control charts is important. CRMs can be used for internal quality control. It is up to 
individual laboratories to define the frequency of use of internal quality control samples 
based on the total number of samples analysed per year. The results obtained from internal 
quality control samples should be reported on appropriate control charts, using graphical and 
statistical methods for interpretation. If quality control data are found to be outside of pre-
defined criteria, action shall be taken to identify and eliminate the problem. 
9 Proficiency testing — ISO/IEC 17025, Section 5.9 
 
The advisory documents Guidance on the level and frequency of proficiency testing 
participation and ILAC Policy for Participation in Proficiency Testing Activities [29, 30] give 
guidance on the level and frequency of proficiency testing (PT) participation. The document 
does not state a fixed number of tests to be performed within a specified period of time, 
which still is a requirement from accreditation bodies (EA members) in some countries. 
Rather, Guidance on the level and frequency of proficiency testing participation says that it is 
up to individual laboratories to define their level and frequency of participation after careful 
consideration of their other quality management measures. Other quality assurance measures 
may include (but are not limited to): 
• regular use of CRMs, 
• comparisons of analysis by independent techniques, 
• use of internal quality control measures, 
• other inter/intralaboratory comparisons, e.g. analysis of blind samples within the 
laboratory. 
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Note: Beside the above, conclusions about the performance of a laboratory could also be 
drawn from the comparison of data obtained during ILCs organised for method validation or 
CRM characterisation [29]. 
 
Besides the above mentioned quality assurance measures, the level of risk may influence the 
level and frequency of proficiency testing participation: 
• number of tests undertaken, 
• turnover of technical staff, 
• experience and knowledge of technical staff, 
• source of traceability (use of CRMs or other materials), 
• known stability/instability of the analytical procedure. 
 
9.1 Level of participation 
 
The document Guidance on the level and frequency of proficiency testing participation 
acknowledges that it is unlikely to be feasible for a laboratory to participate in a specific PT 
for every analytical procedure, GM event content and every products. Instead, laboratories 
should identify groups of products on which the outcome of a PT can serve as a proof of the 
competence of the laboratory for this specific group of products.  
 
With reference to products to be tested, different products may be included in the same 
group. Provided that they have a similar behaviour during GM quantification, the number of 
groups determines the number of product specific PTs a laboratory should participate in. 
 
The minimum frequency of participation for each sub-discipline should be identified by the 
laboratory. The basis for determining the minimum level should originate from the 
assessment of the level of risk. 
 
In all cases, a laboratory must be able to justify the technical arguments for determining the 
level and frequency of PT participation. The justification should be documented. 
9.2 Proficiency testing strategy 
 
According to ISO/IEC 17025:2005 [1, Section 5.9.1], quality control procedures should be 
planned activities. Once the level and frequency of participation have been established, 
laboratories should develop a proficiency testing (PT) strategy for which the content and 
extent of this strategy will depend on the circumstances and scope of the individual 
laboratory and the availability of PT schemes. The strategy should be a part of the 
laboratory’s overall quality control strategy. The document Guidance on the level and 
frequency of proficiency testing participation recommends that the strategy covers at least 
one accreditation cycle (period between two full assessments). Furthermore, the laboratory 
should review the strategy annually and evaluate its appropriateness. 
 
Example: 
This example concerns a GMO testing laboratory for food, feed and seed, which is accredited 
for the following testing activities: 
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• detection and quantification of MON810 maize, MIR162 maize and GTS 40-3-2 soya 
in feed, 
• detection and quantification of MON810 maize, MIR162 maize and GTS 40-3-2 soya 
in food, 
• detection and quantification of MON810 maize, MIR162 maize and GTS 40-3-2 soya 
in seed. 
 
The laboratory identifies that it uses the same measurement technique (qPCR) for food, feed 
and seed, but is using a different sample preparation and DNA extraction method for seeds 
compared to food and feed. Although different GM events may be considered as different 
parameters, the laboratory can justify and demonstrate equivalence between the qPCR 
methods for MON810 maize, MIR162 maize and GTS 40-3-2 soya by method verification 
data. In this case the resulting sub-disciplines would be: 
• detection and quantification of GM maize and soya in feed and food 
• detection and quantification of GM maize and soya in seeds 
10 Summary 
 
The quantification of GMO by qPCR is well established in European GMO testing 
laboratories even if the measurement principle as such is, compared to more traditional 
chemical analytical methods, relatively recent. During those last 10 years, a number of GM 
testing laboratories have obtained an ISO/IEC 17025 accreditation from their national 
accreditation bodies. However, the ISO/IEC 17025 standard has been interpreted in various 
ways and a harmonised specific guidance for the accreditation of laboratories performing 
GMO testing useful for both assessors and testing laboratories was missing. 
 
This document justifies the need for flexible scope accreditation of GMO testing laboratories. 
Furthermore it covers two major points relevant for both parties. First, it gives a detailed 
guidance on the interpretation of ISO/IEC 17025 for those undertaking the GMO testing. 
Guidance is provided for specific ISO/IEC17025 sections that were interpreted differently or 
needed further explanation. 
Secondly, the document outlines on which basis a flexible scope of accreditation can be 
granted. It explains the different levels where flexibility is possible and provides the 
additional specific requirements. 
 
This guidance document should allow a better harmonisation of the accreditation process and 
should facilitate the work of both assessors and GMO testing laboratories. 
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